ConductScience.org, home

Paper26536664

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.

ter Weele EJ and 8 others. Oncotarget, 2015. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts. Papers, record 26536664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26536664

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
PubMed
Journal
Oncotarget
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2021-12-03
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1ter Weele EJEva J
2Terwisscha van Scheltinga AGAnton G T
3Kosterink JGJos G W
4Pot LLinda
5Vedelaar SRSilke R
6Lamberts LELaetitia E
7Williams SPSimon P
8Lub-de Hooge MNMarjolijn N
9de Vries EGElisabeth G E

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
GPI-Linked ProteinsMajor topic
ImmunoconjugatesMajor topic
Pancreatic NeoplasmsMajor topic
Animals
Benzenesulfonates
Cell Line, Tumor
Cytoplasm
Humans
Immunohistochemistry
Indoles
Male
Mesothelin
Mice, Inbred BALB C
Mice, Nude
Microscopy, Fluorescence
Positron-Emission Tomography
Radioisotopes
Time Factors
Tissue Distribution
Transplantation, Heterologous
Zirconium

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119443585Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.J Nucl Med2009https://conductscience.org/library/papers/19443585PubMed
220346868Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.Nucl Med Biol2010https://conductscience.org/library/papers/20346868PubMed
320072072Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.Nucl Med Commun2010https://conductscience.org/library/papers/20072072PubMed
420357763Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer.Clin Pharmacol Ther2010https://conductscience.org/library/papers/20357763PubMed
52039533789Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.J Nucl Med2010https://conductscience.org/library/papers/20395337PubMed
621718943In vivo biodistribution and accumulation of 89Zr in mice.Nucl Med Biol2011https://conductscience.org/library/papers/21718943PubMed
721990576Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.J Nucl Med2011https://conductscience.org/library/papers/21990576PubMed
822072706PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.J Nucl Med2011https://conductscience.org/library/papers/22072706PubMed
922759592Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu.Curr Opin Gastroenterol2012https://conductscience.org/library/papers/22759592PubMed
1022896693The pancreas cancer microenvironment.Clin Cancer Res2012https://conductscience.org/library/papers/22896693PubMed
1123096166PET/CT of cancer patients: part 1, pancreatic neoplasms.AJR Am J Roentgenol2012https://conductscience.org/library/papers/23096166PubMed
1223062948ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models.Nucl Med Biol2013https://conductscience.org/library/papers/23062948PubMed
1324154601Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.Sci Transl Med2013https://conductscience.org/library/papers/24154601PubMed
1424989332
Phase 1 study of the antimesothelin immunotoxin SS1P in combination with pemetrexed and cisplatin for front-line therapy of pleural mesothelioma and correlation of tumor response with serum mesothelin, megakaryocyte potentiating factor, and cancer antigen 125.
Cancer2014https://conductscience.org/library/papers/24989332PubMed
1525453051Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.J Nucl Med2014https://conductscience.org/library/papers/25453051PubMed
1625756664Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging.Oncotarget2015https://conductscience.org/library/papers/25756664PubMed
1726172299Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.Oncotarget2015https://conductscience.org/library/papers/26172299PubMed
1826823490Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer.Mol Cancer Ther2016https://conductscience.org/library/papers/26823490PubMed
1911751476Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).Clin Cancer Res2001https://conductscience.org/library/papers/11751476PubMed
2012827615Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.Hum Pathol2003https://conductscience.org/library/papers/12827615PubMed

See all 25 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42638115Immuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study.Biomark Res2026https://conductscience.org/library/papers/42638115PubMed
42319928Universal diseased-site targeting via glycolysis-driven lactic acid gradient.Sci Adv2026https://conductscience.org/library/papers/42319928PubMed
41994562Mesothelin biology and the evolving landscape of targeted immunotherapy.Mol Ther Oncol2026https://conductscience.org/library/papers/41994562PubMed
36348391Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.Exp Hematol Oncol2022https://conductscience.org/library/papers/36348391PubMed
34203923Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?Int J Mol Sci2021https://conductscience.org/library/papers/34203923PubMed
33327644Analytical Methods for the Detection and Quantification of ADCs in Biological Matrices.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33327644PubMed
33106429Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/33106429PubMed
32517181From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32517181PubMed
32235331Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine.Cancers (Basel)2020https://conductscience.org/library/papers/32235331PubMed
3165875599mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2019https://conductscience.org/library/papers/31658755PubMed
31057683Progress of Coordination and Utilization of Zirconium-89 for Positron Emission Tomography (PET) Studies.Nucl Med Mol Imaging2019https://conductscience.org/library/papers/31057683PubMed
30541081In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.ILAR J2018https://conductscience.org/library/papers/30541081PubMed
30370812Application of Immuno-PET in Antibody-Drug Conjugate Development.Mol Imaging2018https://conductscience.org/library/papers/30370812PubMed
29656320The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.Target Oncol2018https://conductscience.org/library/papers/29656320PubMed
28915667Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography.Oncotarget2017https://conductscience.org/library/papers/28915667PubMed
28638489Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.Theranostics2017https://conductscience.org/library/papers/28638489PubMed
28303026Strategies and challenges for the next generation of antibody-drug conjugates.Nat Rev Drug Discov2017https://conductscience.org/library/papers/28303026PubMed
27252651Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?Front Pharmacol2016https://conductscience.org/library/papers/27252651PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MSLN10232PubTator's text mininghttps://conductscience.org/library/genes/10232

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26536664

GET https://conductscience.org/api/papers/v1/26536664/references?page=2